Supriya Lifescience Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Supriya Lifescience's board has approved the financial results for the quarter ended June 30, 2025. Revenue from operations for the quarter was ₹145.07 crore, a decrease from ₹160.63 crore in the same quarter last year. Net profit stood at ₹34.79 crore, down from ₹44.64 crore year-on-year. Earnings per share were ₹4.32. The company also updated its Nomination & Remuneration Policy, Materiality of Events Policy, and Insider Trading Code, aiming to enhance corporate governance.